General dietary information — not medical advice
Free during the closed trial

A GLP-1 can be hard. Mostly, it's the food.

Track your meals, symptoms and injection timing in one place. Food Signals shows how they tend to line up — so you can plan around your own patterns and eat in a way your body can handle.

Get Free Early Access →

Free during the trial · No credit card · Works in your browser now

Handed a flyer at your clinic or pharmacy? You're in the right place.

What you get free during the trial

Log your day in seconds

Meals by photo, a quick note, or repeating a previous one. The symptoms that matter to you, with severity. Water, and injection timing once a week.

See your week clearly

One Journal timeline of meals, symptoms, water and injections — and how food and timing tend to line up with your rougher days.

Know what to eat

Recipes scored for common GLP-1 side effects, and protein and nutrient tracking against targets set for you.

Coming soon Symptom outlook · injection-cycle patterns · sharing with your dietitian (consent-based) · long-term trend reports

Common questions

Is this really free?
Yes — it's free during our closed trial, and we'll give you plenty of notice before any paid features are introduced. Early trial members will also receive founding-member benefits we're currently finalising.
What does the app track?
Meals (by photo, text, or selecting a previous meal), the symptoms that matter to you and their severity, water intake, and GLP-1 injection timing. From these logs the app surfaces how your meals and symptoms tend to line up.
Do I need to be on a specific medication?
No — it works for anyone on a GLP-1, whatever the brand or dose. Your setup calibrates the app to your own situation.
Is this medical advice?
No. We provide general dietary information based on nutritional science and GLP-1 tolerability research. Always consult your prescribing doctor, pharmacist or registered dietitian before making dietary changes, and never use the app to make decisions about your medication.